caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1790774701

Julie KishM. D., FACP

PRACTICEMOFFITT CANCER CENTER & RESEARCH INSTITUTESee all providers at this practice →
Medical OncologyTampa, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Julie Kish's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Jimmy Caudell
Radiation Oncology · Jackson, MS
381,798
TROTTI, ANDREA352,312
Peter Johnstone
Radiation Oncology · Tampa, FL
22109
Claudia Berman
Diagnostic Radiology · Tampa, FL
1745
John Arrington
Diagnostic Radiology · Tampa, FL
1455
Trevor Rose
Diagnostic Radiology · Tampa, FL
1448
MCCAFFREY, JUDITH1493
Sarah Hoffe
Radiation Oncology · Tampa, FL
1485
Daniel Fernandez
Radiation Oncology · Tampa, FL
1251
Laboratory Corporation Of America
Clinical Laboratory · Tampa, FL
1166
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
475
Unique beneficiaries
—
Total services
742
Distinct HCPCS
6
Medicare payment
$76K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 212 Medical Oncology providers in FL — below median (cohort median 1,224).
PRESCRIBING · PART D · 2024
Total Rx claims
614
Beneficiaries
—
Total drug cost
$3.0M
Distinct drugs
14
Brand share
41.2%
Top prescribed drugs
Prednisone113 claims
Enzalutamide80 claims
Abiraterone Acetate76 claims
Relugolix70 claims
Prochlorperazine Maleate55 claims
QUALITY · MIPS · 2024
Final MIPS score
88.0
Quality
74.0
Cost
71.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.55%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$38
Payment records
2
By payment type
Food and Beverage$38